Art

J-GLOBAL ID：202002247832876273   Reference number：20A1739608

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses

TおよびiNKT細胞応答の誘導のための樹状細胞を標的とするアプローチとしてのリポベースワクチン【JST・京大機械翻訳】

Author (15)： Stolk Dorian A. (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  de Haas Aram (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Vree Jana (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Vree Jana (Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Duinkerken Sanne (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Luebbers Joyce (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  van de Ven Rieneke (Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  van de Ven Rieneke (Department of Otolaryngology/Head and Neck Surgery, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Ambrosini Martino (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Kalay Hakan (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  Bruijns Sven (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  van der Vliet Hans J. (Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  van der Vliet Hans J. (LAVA Therapeutics, Utrecht, Netherlands) ,  de Gruijl Tanja D. (Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands) ,  van Kooyk Yvette (Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Infection and Immunity Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands)
Material： Frontiers in Immunology (Web)
Volume： 11  Page： 990  Publication year： 2020 
JST Material Number： U7074A  ISSN： 1664-3224  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： In this study we developed a l...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1739608&from=J-GLOBAL&jstjournalNo=U7074A") }}

Thesaurus term： peptide ,  antigen ,  tumor ,  human(primates) ,  *vaccine ,  tumor antigen ,  liposome ,  *T cell ,  vaccination ,  Langerhans cell ,  *dendritic cell ,  targeting
Semi thesaurus term： CD8陽性T細胞 ,  *iNKT細胞 ,  ナチュラルキラーT細胞 , 【Automatic Indexing@JST】

Author keywords (8)： dendritic cell ,  DC-SIGN ,  langerin ,  liposome ,  targeting ,  iNKT ,  cancer vaccine ,  T-cell priming

JST classification (2)： Tumor immunity  (ED03040A) ,  Immunological reaction in general  (ED03010T)

Reference (77)：

• Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. (2010) 363:711-23. doi: 10.1056/NEJMoa1003466
• Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. (2015) 373:23-34. doi: 10.1056/NEJMoa1504030
• Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski PJ, Grob J, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. (2017) 377:1345-56. doi: 10.1056/NEJMoa1504030
• Robert C, Thomas L, Bondarenko I, O'Day S, Weber J, Garbe C, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. (2011) 364:2517-26. doi: 10.1056/NEJMoa1104621
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. (1998) 392:245-52. doi: 10.1038/32588

Terms in the title (5)： iNKT細胞 ,  応答 ,  誘導 ,  樹状細胞 ,  標的